Global Non-Oncology Precision Medicine Market Research Report 2025(Status and Outlook)

March 2025 | 241 pages | ID: G01168C4F9A6EN
Bosson Research

Abstracts

Report Overview

In the non-oncology precision medicine market, the application of molecular biology is to study the etiology of diseases other than cancer at the molecular level, so target-based therapy or individualized therapy can be used to cure patients' health-related problems.

This report provides a deep insight into the global Non-Oncology Precision Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-Oncology Precision Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-Oncology Precision Medicine market in any manner.

Global Non-Oncology Precision Medicine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott Laboratories

Agilent Technologies

Inc.

Asuragen

Inc.

Almac Group

AstraZeneca PLC

Bristol Myers Squibb

bioMйrieux SA.

BGI

Danaher Corp.

Illumina

Inc.

Invitae Corporation

Opko Health

Inc.

Teva Pharmaceutical Industries Ltd.

Market Segmentation (by Type)

Applied Sciences

Precision Diagnostics

Digital Health and Information Technology

Precision Therapeutics

Market Segmentation (by Application)

Infectious Diseases

Neurology

Cardiovascular

Lifestyle and Endocrinology

Gastroenterology

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Non-Oncology Precision Medicine Market
• Overview of the regional outlook of the Non-Oncology Precision Medicine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Oncology Precision Medicine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Non-Oncology Precision Medicine
1.2 Key Market Segments
1.2.1 Non-Oncology Precision Medicine Segment by Type
1.2.2 Non-Oncology Precision Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Non-Oncology Precision Medicine Market Overview
2.1 Global Market Overview
2.1.1 Global Non-Oncology Precision Medicine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Non-Oncology Precision Medicine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Non-Oncology Precision Medicine Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Non-Oncology Precision Medicine Product Life Cycle
3.3 Global Non-Oncology Precision Medicine Sales by Manufacturers (2020-2025)
3.4 Global Non-Oncology Precision Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Non-Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Non-Oncology Precision Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Non-Oncology Precision Medicine Manufacturing Sites, Area Served, Product Type
3.8 Non-Oncology Precision Medicine Market Competitive Situation and Trends
3.8.1 Non-Oncology Precision Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Non-Oncology Precision Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Non-Oncology Precision Medicine Industry Chain Analysis
4.1 Non-Oncology Precision Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Non-Oncology Precision Medicine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Non-Oncology Precision Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Non-Oncology Precision Medicine Market
5.7 ESG Ratings of Leading Companies
6 Global Non-Oncology Precision Medicine Market by Region
6.1 Global Non-Oncology Precision Medicine Market Size by Region
6.1.1 Global Non-Oncology Precision Medicine Market Size by Region
6.1.2 Global Non-Oncology Precision Medicine Market Size Market Share by Region
6.2 Global Non-Oncology Precision Medicine Sales by Region
6.2.1 Global Non-Oncology Precision Medicine Sales by Region
6.2.2 Global Non-Oncology Precision Medicine Sales Market Share by Region
7 North America Market Overview
7.1 North America Non-Oncology Precision Medicine Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Non-Oncology Precision Medicine Market Size by Type
7.3 North America Non-Oncology Precision Medicine Market Size by Application
8 Europe Market Overview
8.1 Europe Non-Oncology Precision Medicine Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Non-Oncology Precision Medicine Market Size by Type
8.3 Europe Non-Oncology Precision Medicine Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Non-Oncology Precision Medicine Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Non-Oncology Precision Medicine Market Size by Type
9.3 Asia-Pacific Non-Oncology Precision Medicine Market Size by Application
10 South America Market Overview
10.1 South America Non-Oncology Precision Medicine Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Non-Oncology Precision Medicine Market Size by Type
10.3 South America Non-Oncology Precision Medicine Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Non-Oncology Precision Medicine Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Non-Oncology Precision Medicine Market Size by Type
11.3 Middle East and Africa Non-Oncology Precision Medicine Market Size by Application
12 Non-Oncology Precision Medicine Market Production by Region
12.1 Global Production of Non-Oncology Precision Medicine by Region(2020-2025)
12.2 Global Non-Oncology Precision Medicine Revenue Market Share by Region (2020-2025)
12.3 Global Non-Oncology Precision Medicine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Non-Oncology Precision Medicine Production
12.4.1 North America Non-Oncology Precision Medicine Production Growth Rate (2020-2025)
12.4.2 North America Non-Oncology Precision Medicine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Non-Oncology Precision Medicine Production
12.5.1 Europe Non-Oncology Precision Medicine Production Growth Rate (2020-2025)
12.5.2 Europe Non-Oncology Precision Medicine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Non-Oncology Precision Medicine Production (2020-2025)
12.6.1 Japan Non-Oncology Precision Medicine Production Growth Rate (2020-2025)
12.6.2 Japan Non-Oncology Precision Medicine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Non-Oncology Precision Medicine Production (2020-2025)
12.7.1 China Non-Oncology Precision Medicine Production Growth Rate (2020-2025)
12.7.2 China Non-Oncology Precision Medicine Production, Revenue, Price and Gross Margin (2020-2025)
13 Non-Oncology Precision Medicine Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Non-Oncology Precision Medicine Sales Market Share by Type (2020-2033)
13.3 Global Non-Oncology Precision Medicine Market Size Market Share by Type (2020-2033)
13.4 Global Non-Oncology Precision Medicine Price by Type (2020-2033)
14 Non-Oncology Precision Medicine Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Non-Oncology Precision Medicine Market Sales by Application (2020-2033)
14.3 Global Non-Oncology Precision Medicine Market Size (M USD) by Application (2020-2033)
14.4 Global Non-Oncology Precision Medicine Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Abbott Laboratories
15.1.1 Abbott Laboratories Basic Information
15.1.2 Abbott Laboratories Non-Oncology Precision Medicine Product Overview
15.1.3 Abbott Laboratories Non-Oncology Precision Medicine Product Market Performance
15.1.4 Abbott Laboratories Business Overview
15.1.5 Abbott Laboratories SWOT Analysis
15.1.6 Abbott Laboratories Recent Developments
15.2 Agilent Technologies
15.2.1 Agilent Technologies Basic Information
15.2.2 Agilent Technologies Non-Oncology Precision Medicine Product Overview
15.2.3 Agilent Technologies Non-Oncology Precision Medicine Product Market Performance
15.2.4 Agilent Technologies Business Overview
15.2.5 Agilent Technologies SWOT Analysis
15.2.6 Agilent Technologies Recent Developments
15.3 Inc.
15.3.1 Inc. Basic Information
15.3.2 Inc. Non-Oncology Precision Medicine Product Overview
15.3.3 Inc. Non-Oncology Precision Medicine Product Market Performance
15.3.4 Inc. Business Overview
15.3.5 Inc. SWOT Analysis
15.3.6 Inc. Recent Developments
15.4 Asuragen
15.4.1 Asuragen Basic Information
15.4.2 Asuragen Non-Oncology Precision Medicine Product Overview
15.4.3 Asuragen Non-Oncology Precision Medicine Product Market Performance
15.4.4 Asuragen Business Overview
15.4.5 Asuragen Recent Developments
15.5 Inc.
15.5.1 Inc. Basic Information
15.5.2 Inc. Non-Oncology Precision Medicine Product Overview
15.5.3 Inc. Non-Oncology Precision Medicine Product Market Performance
15.5.4 Inc. Business Overview
15.5.5 Inc. Recent Developments
15.6 Almac Group
15.6.1 Almac Group Basic Information
15.6.2 Almac Group Non-Oncology Precision Medicine Product Overview
15.6.3 Almac Group Non-Oncology Precision Medicine Product Market Performance
15.6.4 Almac Group Business Overview
15.6.5 Almac Group Recent Developments
15.7 AstraZeneca PLC
15.7.1 AstraZeneca PLC Basic Information
15.7.2 AstraZeneca PLC Non-Oncology Precision Medicine Product Overview
15.7.3 AstraZeneca PLC Non-Oncology Precision Medicine Product Market Performance
15.7.4 AstraZeneca PLC Business Overview
15.7.5 AstraZeneca PLC Recent Developments
15.8 Bristol Myers Squibb
15.8.1 Bristol Myers Squibb Basic Information
15.8.2 Bristol Myers Squibb Non-Oncology Precision Medicine Product Overview
15.8.3 Bristol Myers Squibb Non-Oncology Precision Medicine Product Market Performance
15.8.4 Bristol Myers Squibb Business Overview
15.8.5 Bristol Myers Squibb Recent Developments
15.9 bioMйrieux SA.
15.9.1 bioMйrieux SA. Basic Information
15.9.2 bioMйrieux SA. Non-Oncology Precision Medicine Product Overview
15.9.3 bioMйrieux SA. Non-Oncology Precision Medicine Product Market Performance
15.9.4 bioMйrieux SA. Business Overview
15.9.5 bioMйrieux SA. Recent Developments
15.10 BGI
15.10.1 BGI Basic Information
15.10.2 BGI Non-Oncology Precision Medicine Product Overview
15.10.3 BGI Non-Oncology Precision Medicine Product Market Performance
15.10.4 BGI Business Overview
15.10.5 BGI Recent Developments
15.11 Danaher Corp.
15.11.1 Danaher Corp. Basic Information
15.11.2 Danaher Corp. Non-Oncology Precision Medicine Product Overview
15.11.3 Danaher Corp. Non-Oncology Precision Medicine Product Market Performance
15.11.4 Danaher Corp. Business Overview
15.11.5 Danaher Corp. Recent Developments
15.12 Illumina
15.12.1 Illumina Basic Information
15.12.2 Illumina Non-Oncology Precision Medicine Product Overview
15.12.3 Illumina Non-Oncology Precision Medicine Product Market Performance
15.12.4 Illumina Business Overview
15.12.5 Illumina Recent Developments
15.13 Inc.
15.13.1 Inc. Basic Information
15.13.2 Inc. Non-Oncology Precision Medicine Product Overview
15.13.3 Inc. Non-Oncology Precision Medicine Product Market Performance
15.13.4 Inc. Business Overview
15.13.5 Inc. Recent Developments
15.14 Invitae Corporation
15.14.1 Invitae Corporation Basic Information
15.14.2 Invitae Corporation Non-Oncology Precision Medicine Product Overview
15.14.3 Invitae Corporation Non-Oncology Precision Medicine Product Market Performance
15.14.4 Invitae Corporation Business Overview
15.14.5 Invitae Corporation Recent Developments
15.15 Opko Health
15.15.1 Opko Health Basic Information
15.15.2 Opko Health Non-Oncology Precision Medicine Product Overview
15.15.3 Opko Health Non-Oncology Precision Medicine Product Market Performance
15.15.4 Opko Health Business Overview
15.15.5 Opko Health Recent Developments
15.16 Inc.
15.16.1 Inc. Basic Information
15.16.2 Inc. Non-Oncology Precision Medicine Product Overview
15.16.3 Inc. Non-Oncology Precision Medicine Product Market Performance
15.16.4 Inc. Business Overview
15.16.5 Inc. Recent Developments
15.17 Teva Pharmaceutical Industries Ltd.
15.17.1 Teva Pharmaceutical Industries Ltd. Basic Information
15.17.2 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product Overview
15.17.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product Market Performance
15.17.4 Teva Pharmaceutical Industries Ltd. Business Overview
15.17.5 Teva Pharmaceutical Industries Ltd. Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Non-Oncology Precision Medicine Market Size by Type (M USD)
Table 4. Global Non-Oncology Precision Medicine Market Size by Application (M USD)
Table 5. Non-Oncology Precision Medicine Market Size Comparison by Region (M USD)
Table 6. Global Non-Oncology Precision Medicine Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Non-Oncology Precision Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Non-Oncology Precision Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Non-Oncology Precision Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Oncology Precision Medicine as of 2024)
Table 11. Global Market Non-Oncology Precision Medicine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Non-Oncology Precision Medicine Manufacturing Sites and Area Served
Table 13. Manufacturers Non-Oncology Precision Medicine Product Type
Table 14. Global Non-Oncology Precision Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-Oncology Precision Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Non-Oncology Precision Medicine Market Size Comparison by Region (M USD)
Table 26. Global Non-Oncology Precision Medicine Market Size by Region (2020-2033) & (M USD)
Table 27. Global Non-Oncology Precision Medicine Market Size Market Share by Region (2020-2033)
Table 28. Global Non-Oncology Precision Medicine Sales by Region (2020-2033) & (K Units)
Table 29. Global Non-Oncology Precision Medicine Sales Market Share by Region (2020-2033)
Table 30. North America Non-Oncology Precision Medicine Market Size by Country (2020-2033) & (M USD)
Table 31. North America Non-Oncology Precision Medicine Sales by Country (2020-2033) & (K Units)
Table 32. North America Non-Oncology Precision Medicine Sales by Type (K Units)
Table 33. North America Non-Oncology Precision Medicine Market Size by Type (M USD)
Table 34. North America Non-Oncology Precision Medicine Sales (K Units) by Type (2020-2033)
Table 35. North America Non-Oncology Precision Medicine Market Size (M USD) by Type (2020-2033)
Table 36. North America Non-Oncology Precision Medicine Sales by Application (K Units)
Table 37. North America Non-Oncology Precision Medicine Market Size by Application (M USD)
Table 38. North America Non-Oncology Precision Medicine Sales (K Units) by Application (2020-2033)
Table 39. North America Non-Oncology Precision Medicine Market Size (M USD) by Application (2020-2033)
Table 40. Europe Non-Oncology Precision Medicine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Non-Oncology Precision Medicine Sales by Country (2020-2033) & (K Units)
Table 42. Europe Non-Oncology Precision Medicine Sales by Type (K Units)
Table 43. Europe Non-Oncology Precision Medicine Market Size by Type (M USD)
Table 44. Europe Non-Oncology Precision Medicine Sales (K Units) by Type (2020-2033)
Table 45. Europe Non-Oncology Precision Medicine Market Size (M USD) by Type (2020-2033)
Table 46. Europe Non-Oncology Precision Medicine Sales by Application (K Units)
Table 47. Europe Non-Oncology Precision Medicine Market Size by Application (M USD)
Table 48. Europe Non-Oncology Precision Medicine Sales (K Units) by Application (2020-2033)
Table 49. Europe Non-Oncology Precision Medicine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Non-Oncology Precision Medicine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Non-Oncology Precision Medicine Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Non-Oncology Precision Medicine Sales by Type (K Units)
Table 53. Asia-Pacific Non-Oncology Precision Medicine Market Size by Type (M USD)
Table 54. Asia-Pacific Non-Oncology Precision Medicine Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Non-Oncology Precision Medicine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Non-Oncology Precision Medicine Sales by Application (K Units)
Table 57. Asia-Pacific Non-Oncology Precision Medicine Market Size by Application (M USD)
Table 58. Asia-Pacific Non-Oncology Precision Medicine Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Non-Oncology Precision Medicine Market Size (M USD) by Application (2020-2025)
Table 60. South America Non-Oncology Precision Medicine Market Size by Country (2020-2033) & (M USD)
Table 61. South America Non-Oncology Precision Medicine Sales by Country (2020-2033) & (K Units)
Table 62. South America Non-Oncology Precision Medicine Sales by Type (K Units)
Table 63. South America Non-Oncology Precision Medicine Market Size by Type (M USD)
Table 64. South America Non-Oncology Precision Medicine Sales (K Units) by Type (2020-2033)
Table 65. South America Non-Oncology Precision Medicine Market Size (M USD) by Type (2020-2033)
Table 66. South America Non-Oncology Precision Medicine Sales by Application (K Units)
Table 67. South America Non-Oncology Precision Medicine Market Size by Application (M USD)
Table 68. South America Non-Oncology Precision Medicine Sales (K Units) by Application (2020-2033)
Table 69. South America Non-Oncology Precision Medicine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Non-Oncology Precision Medicine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Non-Oncology Precision Medicine Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Non-Oncology Precision Medicine Sales by Type (K Units)
Table 73. Middle East and Africa Non-Oncology Precision Medicine Market Size by Type (M USD)
Table 74. Middle East and Africa Non-Oncology Precision Medicine Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Non-Oncology Precision Medicine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Non-Oncology Precision Medicine Sales by Application (K Units)
Table 77. Middle East and Africa Non-Oncology Precision Medicine Market Size by Application (M USD)
Table 78. Middle East and Africa Non-Oncology Precision Medicine Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Non-Oncology Precision Medicine Market Size (M USD) by Application (2020-2033)
Table 80. Global Non-Oncology Precision Medicine Production (K Units) by Region(2020-2025)
Table 81. Global Non-Oncology Precision Medicine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Non-Oncology Precision Medicine Revenue Market Share by Region (2020-2025)
Table 83. Global Non-Oncology Precision Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Non-Oncology Precision Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Non-Oncology Precision Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Non-Oncology Precision Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Non-Oncology Precision Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Non-Oncology Precision Medicine Sales by Type (K Units)
Table 89. Global Non-Oncology Precision Medicine Market Size by Type (M USD)
Table 90. Global Non-Oncology Precision Medicine Sales (K Units) by Type (2020-2033)
Table 91. Global Non-Oncology Precision Medicine Sales Market Share by Type (2020-2033)
Table 92. Global Non-Oncology Precision Medicine Market Size (M USD) by Type (2020-2033)
Table 93. Global Non-Oncology Precision Medicine Market Size Share by Type (2020-2033)
Table 94. Global Non-Oncology Precision Medicine Sales (K Units) by Application
Table 95. Global Non-Oncology Precision Medicine Market Size by Application(M USD)
Table 96. Global Non-Oncology Precision Medicine Sales by Application (2020-2033) & (K Units)
Table 97. Global Non-Oncology Precision Medicine Sales Market Share by Application (2020-2033)
Table 98. Global Non-Oncology Precision Medicine Market Size by Application (2020-2033) & (M USD)
Table 99. Global Non-Oncology Precision Medicine Market Share by Application (2020-2033)
Table 100. Global Non-Oncology Precision Medicine Sales Growth Rate by Application (2020-2033)
Table 101. Abbott Laboratories Basic Information
Table 102. Abbott Laboratories Non-Oncology Precision Medicine Product Overview
Table 103. Abbott Laboratories Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Abbott Laboratories Business Overview
Table 105. Abbott Laboratories SWOT Analysis
Table 106. Abbott Laboratories Recent Developments
Table 107. Agilent Technologies Basic Information
Table 108. Agilent Technologies Non-Oncology Precision Medicine Product Overview
Table 109. Agilent Technologies Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Agilent Technologies Business Overview
Table 111. Agilent Technologies SWOT Analysis
Table 112. Agilent Technologies Recent Developments
Table 113. Inc. Basic Information
Table 114. Inc. Non-Oncology Precision Medicine Product Overview
Table 115. Inc. Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Inc. Business Overview
Table 117. Inc. SWOT Analysis
Table 118. Inc. Recent Developments
Table 119. Asuragen Basic Information
Table 120. Asuragen Non-Oncology Precision Medicine Product Overview
Table 121. Asuragen Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Asuragen Business Overview
Table 123. Asuragen Recent Developments
Table 124. Inc. Basic Information
Table 125. Inc. Non-Oncology Precision Medicine Product Overview
Table 126. Inc. Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Inc. Business Overview
Table 128. Inc. Recent Developments
Table 129. Almac Group Basic Information
Table 130. Almac Group Non-Oncology Precision Medicine Product Overview
Table 131. Almac Group Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Almac Group Business Overview
Table 133. Almac Group Recent Developments
Table 134. AstraZeneca PLC Basic Information
Table 135. AstraZeneca PLC Non-Oncology Precision Medicine Product Overview
Table 136. AstraZeneca PLC Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. AstraZeneca PLC Business Overview
Table 138. AstraZeneca PLC Recent Developments
Table 139. Bristol Myers Squibb Basic Information
Table 140. Bristol Myers Squibb Non-Oncology Precision Medicine Product Overview
Table 141. Bristol Myers Squibb Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Bristol Myers Squibb Business Overview
Table 143. Bristol Myers Squibb Recent Developments
Table 144. bioMйrieux SA. Basic Information
Table 145. bioMйrieux SA. Non-Oncology Precision Medicine Product Overview
Table 146. bioMйrieux SA. Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. bioMйrieux SA. Business Overview
Table 148. bioMйrieux SA. Recent Developments
Table 149. BGI Basic Information
Table 150. BGI Non-Oncology Precision Medicine Product Overview
Table 151. BGI Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. BGI Business Overview
Table 153. BGI Recent Developments
Table 154. Danaher Corp. Basic Information
Table 155. Danaher Corp. Non-Oncology Precision Medicine Product Overview
Table 156. Danaher Corp. Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Danaher Corp. Business Overview
Table 158. Danaher Corp. Recent Developments
Table 159. Illumina Basic Information
Table 160. Illumina Non-Oncology Precision Medicine Product Overview
Table 161. Illumina Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Illumina Business Overview
Table 163. Illumina Recent Developments
Table 164. Inc. Basic Information
Table 165. Inc. Non-Oncology Precision Medicine Product Overview
Table 166. Inc. Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Inc. Business Overview
Table 168. Inc. Recent Developments
Table 169. Invitae Corporation Basic Information
Table 170. Invitae Corporation Non-Oncology Precision Medicine Product Overview
Table 171. Invitae Corporation Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Invitae Corporation Business Overview
Table 173. Invitae Corporation Recent Developments
Table 174. Opko Health Basic Information
Table 175. Opko Health Non-Oncology Precision Medicine Product Overview
Table 176. Opko Health Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Opko Health Business Overview
Table 178. Opko Health Recent Developments
Table 179. Inc. Basic Information
Table 180. Inc. Non-Oncology Precision Medicine Product Overview
Table 181. Inc. Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 182. Inc. Business Overview
Table 183. Inc. Recent Developments
Table 184. Teva Pharmaceutical Industries Ltd. Basic Information
Table 185. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product Overview
Table 186. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 187. Teva Pharmaceutical Industries Ltd. Business Overview
Table 188. Teva Pharmaceutical Industries Ltd. Recent Developments
List of Figures
Figure 1. Product Picture of Non-Oncology Precision Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-Oncology Precision Medicine Market Size (M USD), 2024-2033
Figure 5. Global Non-Oncology Precision Medicine Market Size (M USD) (2020-2033)
Figure 6. Global Non-Oncology Precision Medicine Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-Oncology Precision Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Non-Oncology Precision Medicine Product Life Cycle
Figure 13. Non-Oncology Precision Medicine Sales Share by Manufacturers in 2024
Figure 14. Global Non-Oncology Precision Medicine Revenue Share by Manufacturers in 2024
Figure 15. Non-Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Non-Oncology Precision Medicine Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Non-Oncology Precision Medicine Revenue in 2024
Figure 18. Industry Chain Map of Non-Oncology Precision Medicine
Figure 19. Global Non-Oncology Precision Medicine Market PEST Analysis
Figure 20. Global Non-Oncology Precision Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Non-Oncology Precision Medicine Market Size by Region
Figure 27. Global Non-Oncology Precision Medicine Market Size Market Share by Region (2020-2033)
Figure 28. Global Non-Oncology Precision Medicine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Non-Oncology Precision Medicine Market Size (M USD) by Country
Figure 33. USA Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Non-Oncology Precision Medicine Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Non-Oncology Precision Medicine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Non-Oncology Precision Medicine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Non-Oncology Precision Medicine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Non-Oncology Precision Medicine Market Size (M USD)by Type
Figure 40. North America Non-Oncology Precision Medicine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Non-Oncology Precision Medicine Market Size (M USD) by Country
Figure 45. Germany Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Non-Oncology Precision Medicine Market Size (M USD) by Type
Figure 56. Europe Non-Oncology Precision Medicine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Non-Oncology Precision Medicine Market Size (M USD) by Country
Figure 61. China Non-Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Non-Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Non-Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Non-Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Non-Oncology Precision Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Non-Oncology Precision Medicine Market Size (M USD) by Type
Figure 72. Asia-Pacific Non-Oncology Precision Medicine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Non-Oncology Precision Medicine Market Size (M USD) by Country
Figure 77. Brazil Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Non-Oncology Precision Medicine Market Size (M USD) by Type
Figure 84. South America Non-Oncology Precision Medicine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Non-Oncology Precision Medicine Market Size (M USD) by Country
Figure 89. Saudi Arabia Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Non-Oncology Precision Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Non-Oncology Precision Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Non-Oncology Precision Medicine Market Size (M USD) by Type
Figure 100. Middle East and Africa Non-Oncology Precision Medicine Market Size (M USD) by Application
Figure 101. Global Non-Oncology Precision Medicine Production Market Share by Region (2020-2025)
Figure 102. North America Non-Oncology Precision Medicine Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Non-Oncology Precision Medicine Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Non-Oncology Precision Medicine Production (K Units) Growth Rate (2020-2025)
Figure 105. China Non-Oncology Precision Medicine Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Non-Oncology Precision Medicine Market Size by Type (M USD)
Figure 108. Sales Market Share of Non-Oncology Precision Medicine by Type (2020-2033)
Figure 109. Sales Market Share of Non-Oncology Precision Medicine by Type in 2024
Figure 110. Market Size Share of Non-Oncology Precision Medicine by Type (2020-2033)
Figure 111. Market Size Share of Non-Oncology Precision Medicine by Type in 2024
Figure 112. Global Non-Oncology Precision Medicine Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Non-Oncology Precision Medicine Market Size by Application(M USD)
Figure 115. Global Non-Oncology Precision Medicine Market Share by Application
Figure 116. Global Non-Oncology Precision Medicine Sales Market Share by Application (2020-2033)
Figure 117. Global Non-Oncology Precision Medicine Sales Market Share by Application in 2024
Figure 118. Global Non-Oncology Precision Medicine Market Share by Application (2020-2033)
Figure 119. Global Non-Oncology Precision Medicine Market Share by Application in 2024
Figure 120. Global Non-Oncology Precision Medicine Sales Growth Rate by Application (2020-2033)